YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
Quick Stats
Jan 30, 202656.5
AI Score
HOLD0.67
Volume Ratio
Next Earnings
17
+ve Days (30d)
12
-ve Days (30d)
YDES Stock Summary
Last updated Jan 30, 2026
YDES is currently trading at $11.87, positioned below its 200-day moving average of $None, suggesting bearish momentum. The stock has a 52-week range of $7.2 to $25.
Technical Analysis: The 50-day moving average stands at $11.82, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 48.402, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.024, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates YDES at 56.5/100 with a HOLD recommendation.
YDES (YD Bio Limited Ordinary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.402 |
| CMF (20) | -0.024 |
| ROC (10) | 3.94 |
| ADX (14) | 15.649 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.065 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -42.857 |
| MFI (14) | 51.072 |
YDES Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
YDES Price vs Max Options Open Interest
YDES Max Change In Options Open Interest
YDES Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
YDES Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
YDES Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
YDES Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
YD Bio Limited Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
YDES Moving Averages Analysis
YDES (YD Bio Limited Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 11.92 |
| 20 | 11.93 |
| 30 | 11.97 |
| 50 | 11.82 |
| 100 | 13.93 |
| 200 | None |
YDES Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | -- |
| Earnings/Share ($) | -- |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |